Maximal Exercise Capacity in Chronic Kidney Disease Stage 4-5 Patients Transitioning to Renal Replacement Therapy or Continuing Conservative Care: A Longitudinal Follow-Up Study

被引:3
|
作者
Hellman, Tapio [1 ,2 ]
Lankinen, Roosa [1 ,2 ]
Hakamaeki, Markus [1 ,2 ]
Koivuviita, Niina S. [1 ,2 ]
Paerkkae, Jussi [2 ,3 ]
Kallio, Petri [2 ,3 ,4 ,5 ]
Metsaerinne, Kaj [1 ,2 ]
Jaervisalo, Mikko J. [2 ,6 ,7 ]
机构
[1] Turku Univ Hosp, Kidney Ctr, Turku, Finland
[2] Univ Turku, Turku, Finland
[3] Turku Univ Hosp, Dept Clin Physiol, Turku, Finland
[4] Univ Turku, Paavo Nurmi Ctr, Turku, Finland
[5] Univ Turku, Unit Hlth & Phys Act, Turku, Finland
[6] Turku Univ Hosp, Dept Anaesthesiol & Intens Care, Turku, Finland
[7] Turku Univ Hosp, Dept Intens Care, Turku, Finland
关键词
Chronic kidney disease; Ergometry test; Renal replacement therapy; Exercise capacity; SODIUM-BICARBONATE; PERFORMANCE; ASSOCIATION; SURVIVAL;
D O I
10.1159/000520103
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Chronic kidney disease (CKD) is associated with impaired maximal exercise capacity (MEC). However, data are scarce on the development of MEC in CKD stage 4-5 patients transitioning to renal replacement therapy (RRT). Methods: We explored the change in MEC measured in watts (Wlast4) with 2 consecutive maximal bicycle stress ergometry tests in 122 CKD stage 4-5 patients transitioning to dialysis and transplantation in an observational follow-up study. Results: Mean age was 58.9 +/- 13.9 years and 43 (35.2%) were female. Mean time between the baseline and follow-up ergometry tests was 1,012 +/- 327 days and 29 (23.8%) patients had not initiated RRT, 50 (41.0%) were undergoing dialysis, and 43 (35.2%) had received a kidney transplant at the time of the follow-up ergometry test. The mean Wlast4 was 91 +/- 37 W and 84 +/- 37 W for the baseline and follow-up ergometry tests, respectively (p < 0.001). The mean Wlast4 declined between the baseline and follow-up ergometry tests in patients not requiring RRT (p = 0.001) and transplant recipients (p = 0.005), but not in dialysis patients (p = 0.478). There were no differences in the ratio of Wlast4 of the follow-up to the baseline ergometry tests ( increment Wlast4) between patients on different treatment modalities at the time of the follow-up test (p = 0.097). Mean capillary blood bicarbonate was significantly associated with increment Wlast4 after adjusting for age and treatment modality in the multivariate linear regression analysis (beta = 0.226, p = 0.012). Conclusion: MEC declined or remained poor in advanced CKD patients transitioning to RRT or continuing conservative care in this observational study. Mean capillary blood bicarbonate was independently associated with the development of MEC.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 50 条
  • [1] Impact of specialised renal care in patients with chronic kidney disease stage 4-5: the implicate study
    Saudan, P.
    Marangon, N.
    Bourquin, V.
    Hadaya, K.
    Stoermann-Chopard, C.
    Martin, P-Y
    SWISS MEDICAL WEEKLY, 2009, 139 (45-46) : 10S - 10S
  • [2] Systolic blood pressure and the risk of kidney replacement therapy and mortality in patients with chronic kidney disease stage 4-5
    Chavez-Iniguez, Jonathan S.
    Zaragoza, Jose J.
    Camacho-Guerrero, Jahir R.
    Villavicencio-Ceron, Vanessa
    Valdez-Ortiz, Rafael
    Huerta-Orozco, Ana E.
    Chavez-Alonso, Gael
    Oliva-Martinez, Ana E.
    Diaz-Villavicencio, Bladimir
    Calderon-Garcia, Clementina E.
    Gonzalez-Barajas, Jose D.
    Arizaga-Napoles, Manuel
    De La Vega-Mendez, Frida M.
    Gomez-Fregoso, Juan A.
    Rodriguez-Garcia, Francisco G.
    Navarro-Blackaller, Guillermo
    Medina-Gonzalez, Ramon
    Alcantar-Vallin, Luz
    Garcia-Garcia, Guillermo
    KIDNEY & BLOOD PRESSURE RESEARCH, 2023, 48 (01): : 556 - 567
  • [3] Progression of Aortic Calcification in Stage 4-5 Chronic Kidney Disease Patients Transitioning to Dialysis and Transplantation
    Lankinen, Roosa
    Hakamaki, Markus
    Hellman, Tapio
    Koivuviita, Niina S.
    Metsarinne, Kaj
    Jarvisalo, Mikko J.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2022, 47 (01): : 23 - 30
  • [4] Evolution of Quality of Life in Chronic Kidney Disease Stage 4-5 Patients Transitioning to Dialysis and Transplantation
    Hakamaki, Markus
    Jarvisalo, Mikko J.
    Lankinen, Roosa
    Koivuviita, Niina
    Parkka, Jussi P.
    Kozak-Barany, Andrea
    Hellman, Tapio
    Metsarinne, Kaj
    NEPHRON, 2022, 146 (05) : 439 - 448
  • [5] Longitudinal Follow-Up and Outcomes for Chinese Patients with Stage 1-4 Chronic Kidney Disease
    Wang, Jinwei
    Lv, Jicheng
    He, Kevin
    Wang, Fang
    Gao, Bixia
    Zhao, Ming-Hui
    Zhang, Luxia
    KIDNEY DISEASES, 2022, 8 (01) : 72 - 81
  • [6] Final Stage of Chronic Kidney Disease with Conservative Kidney Management or Renal Replacement Therapy: A Primary-Care Population Study
    Bundo, Daniel
    Cunillera, Oriol
    Arbiol-Roca, Ariadna
    Cobo-Guerrero, Silvia
    Romano, Jose
    Gil-Terron, Neus
    Fulladosa, Xavier
    Comas, Jordi
    Rama, Ines
    Cruzado, Josep M.
    Salvador-Gonzalez, Betlem
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [7] Team Care in Preparing Patients with Stage 4 Chronic Kidney Disease tor Renal Replacement Therapy
    Adkins, Jacqueline
    Zimbro, Kathie
    NEPHROLOGY NURSING JOURNAL, 2011, 38 (02) : 193 - 193
  • [8] Mortality at one year follow-up in patients with chronic kidney disease stage 4
    Greloni, Gustavo
    Varela, Federico
    Perman, Gaston
    Michelangelo, Hernan
    Figar, Silvana
    Cecilio, Eleonora
    Waisman, Gabriel
    Algranati, Salomon
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2010, 30 (02): : 51 - 57
  • [9] Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease
    Conway, Bryan
    Webster, Angela
    Ramsay, George
    Morgan, Neal
    Neary, John
    Whitworth, Caroline
    Harty, John
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (06) : 1930 - 1937
  • [10] Characteristics of patients with heart failure and advanced chronic kidney disease (stages 4-5) not undergoing renal replacement therapy (ERCA-IC STUDY)
    Valdivielso, S.
    Vicente Elcano, M.
    Garcia Alonso, A.
    Pascual Sanchez, S.
    Galceran Herrera, I.
    Barbosa Puig, F.
    Belarte Tornero, L. C.
    Ruiz Bustillo, S.
    Morales Murillo, R.
    Barrios Barrera, C.
    Vime Jubany, J.
    Farre Lopez, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 253 - 253